83 related articles for article (PubMed ID: 1317714)
1. Characterization of mitochondrial imidazoline-guanidinium receptive sites (IGRS) in liver.
Tesson F; Prip-Buus C; Lemoine A; Pégorier JP; Parini A
Am J Hypertens; 1992 Apr; 5(4 Pt 2):80S-82S. PubMed ID: 1317714
[TBL] [Abstract][Full Text] [Related]
2. Subcellular distribution of imidazoline-guanidinium-receptive sites in human and rabbit liver. Major localization to the mitochondrial outer membrane.
Tesson F; Prip-Buus C; Lemoine A; Pegorier JP; Parini A
J Biol Chem; 1991 Jan; 266(1):155-60. PubMed ID: 1845963
[TBL] [Abstract][Full Text] [Related]
3. Identification of an imidazoline-guanidinium receptive site in mitochondria from rabbit cerebral cortex.
Tesson F; Parini A
Eur J Pharmacol; 1991 Sep; 208(1):81-3. PubMed ID: 1936130
[TBL] [Abstract][Full Text] [Related]
4. Characterization of imidazoline-guanidinium receptive sites in renal medulla from human kidney.
Lachaud V; Limon I; Tesson F; Coupry I; Parini A
Am J Hypertens; 1992 Apr; 5(4 Pt 2):69S-71S. PubMed ID: 1350730
[TBL] [Abstract][Full Text] [Related]
5. Imidazoline-guanidinium receptive site (IGRS): mitochondrial distribution and regulation properties.
Parini A; Coupry I; Tesson F; Limon I; Gargalidis-Moudanos C
Fundam Clin Pharmacol; 1992; 6 Suppl 1():35S-40S. PubMed ID: 1324212
[No Abstract] [Full Text] [Related]
6. Imidazoline-guanidinium and alpha 2-adrenergic binding sites in basolateral membranes from human kidney.
Lachaud-Pettiti V; Podevin RA; Chrétien Y; Parini A
Eur J Pharmacol; 1991 Jan; 206(1):23-31. PubMed ID: 1648494
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of mitochondrial imidazoline-guanidinium receptive site from rabbit kidney.
Limon I; Coupry I; Lanier SM; Parini A
J Biol Chem; 1992 Oct; 267(30):21645-9. PubMed ID: 1400475
[TBL] [Abstract][Full Text] [Related]
8. Characterization of an imidazoline/guanidinium receptive site distinct from the alpha 2-adrenergic receptor.
Parini A; Coupry I; Graham RM; Uzielli I; Atlas D; Lanier SM
J Biol Chem; 1989 Jul; 264(20):11874-8. PubMed ID: 2545687
[TBL] [Abstract][Full Text] [Related]
9. [Imidazoline-guanidine site: a subtype of imidazoline receptors].
Coupry I; Limon I; Tesson F; Lachaud V; Gargalidis-Moudanos C; Parini A
Therapie; 1992 Nov; 47(6):519-24. PubMed ID: 1338740
[TBL] [Abstract][Full Text] [Related]
10. Tissue-specific localization of mitochondrial imidazoline-guanidinium receptive sites.
Tesson F; Limon I; Parini A
Eur J Pharmacol; 1992 Aug; 219(2):335-8. PubMed ID: 1425960
[TBL] [Abstract][Full Text] [Related]
11. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
Molderings GJ; Likungu J; Jakschik J; Göthert M
Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
[TBL] [Abstract][Full Text] [Related]
12. Use of high affinity, radioiodinated probes for identification of imidazoline/guanidinium receptive sites.
Lanier SM; Lanier B; Bakthavachalam V; McGrath CR; Neumeyer JL
Ann N Y Acad Sci; 1995 Jul; 763():106-11. PubMed ID: 7677319
[TBL] [Abstract][Full Text] [Related]
13. Development of a high-affinity radioiodinated ligand for identification of imidazoline/guanidinium receptive sites (IGRS): intratissue distribution of IGRS in liver, forebrain, and kidney.
Ivkovic B; Bakthavachalam V; Zhang W; Parini A; Diz D; Bosch S; Neumeyer JL; Lanier SM
Mol Pharmacol; 1994 Jul; 46(1):15-23. PubMed ID: 8058049
[TBL] [Abstract][Full Text] [Related]
14. Imidazoline-guanidinium receptive site in renal proximal tubule: asymmetric distribution, regulation by cations and interaction with an endogenous clonidine displacing substance.
Coupry I; Atlas D; Podevin RA; Uzielli I; Parini A
J Pharmacol Exp Ther; 1990 Jan; 252(1):293-9. PubMed ID: 2153803
[TBL] [Abstract][Full Text] [Related]
15. [Selectivity of alpha 2-adrenergic agonists for the imidazoline-guanidine and alpha 2-adrenergic receptors].
Lachaud V; Coupry I; Podevin RA; Koenig E; Parini A
Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1135-7. PubMed ID: 2573323
[TBL] [Abstract][Full Text] [Related]
16. Relationship between imidazoline/guanidinium receptive sites and monoamine oxidase A and B.
Raddatz R; Lanier SM
Neurochem Int; 1997 Jan; 30(1):109-17. PubMed ID: 9116581
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
[TBL] [Abstract][Full Text] [Related]
18. Imidazoline binding sites in fat cells. Localization and pharmacologic differentiation from alpha 2-adrenergic receptors.
Lafontan M; Langin D; Portillo M; Paris H
Am J Hypertens; 1992 Apr; 5(4 Pt 2):72S-79S. PubMed ID: 1350731
[TBL] [Abstract][Full Text] [Related]
19. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
[TBL] [Abstract][Full Text] [Related]
20. [Interaction of rilmenidine with renal imidazoline-guanidine sites].
Lachaud V; Bidet M; Coupry I; Podevin RA; Poujeol P; Parini A
Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():15-8. PubMed ID: 2576516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
